Compound Detail
CHEMBL4757002
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4757002 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | MXMNVDOQPDNWKI-UHFFFAOYSA-N |
4
Targets
4
Activities
1
Assay Types
0
PK Parameters
6
Publications
0
Known Names
Molecular Properties
452.5
MW (Da)
5.23
ALogP
7
HBA
2
HBD
85.4
PSA (Ų)
0.47
QED
1
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 4.58
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| NCI-H1975 | IC50 | = | 26120.0 | nM | 4.58 | Antiproliferation activity against human NCI-H1975 cells harboring EGFR T790M/L8... | 32912435 |
| A549 | IC50 | = | 29640.0 | nM | 4.53 | Antiproliferation activity against human A549 cells assessed as reduction in cel... | 32912435 |
| L02 | IC50 | = | 41230.0 | nM | 4.38 | Cytotoxicity against human L02 cells assessed as reduction in cell viability mea... | 32912435 |
| HeLa | IC50 | = | 44810.0 | nM | 4.35 | Antiproliferation activity against human HeLa cells assessed as reduction in cel... | 32912435 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 32912435 | 10.1016/j.bmc.2020.115669 | A549 | 1 |
| 32912435 | 10.1016/j.bmc.2020.115669 | NCI-H1975 | 1 |
| 32912435 | 10.1016/j.bmc.2020.115669 | HeLa | 1 |
| 32912435 | 10.1016/j.bmc.2020.115669 | MCF7 | 1 |
| 32912435 | 10.1016/j.bmc.2020.115669 | L02 | 1 |
| 32912435 | 10.1016/j.bmc.2020.115669 | Unchecked | 1 |
Data from ChEMBL 36 via Core Engine